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Multi-step immunofluorescent analysis of vitamin D receptor
loci and myosin heavy chain isoforms in human skeletal muscle
Abstract
Vitamin D receptors have been shown to be present in human skeletal muscle using different techniques.
We developed a multi-staining immunofluorescent method to detect vitamin D receptor expression and
co-localize it with myosin heavy chain isoform expression in skeletal muscle biopsies in older female
subjects. Serial sections were cut from frozen samples obtained by needle biopsy of the vastus lateralis.
Samples were probed with a primary vitamin D receptor monoclonal antibody and then re-probed with a
type IIa myosin heavy chain isoform-specific antibody. Independent unfixed sections followed a similar
protocol and were probed with type IIx and type I myosin heavy chain isoform-specific antibodies.
Immunohistochemistry and fluorescent microscopy co-localized vitamin D receptor loci and myosin
heavy chain isoforms in whole skeletal muscle sections. We quantified intranuclear vitamin D receptor
staining patterns and number of individual muscle fiber subtypes within a muscle section.
Immunohistochemical staining of the vitamin D receptor was confirmed by Western blot using the same
monoclonal antibody. This multi-staining immunofluorescent technique allows for measurement of
intranuclear vitamin D receptor expression in the context of the specific muscle fiber type profile in a
single section. This method can thus be a useful approach to study potential relationships between
muscle fiber subtypes and vitamin D receptor expression.
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Abstract
Vitamin D receptors have been shown to be present in human skeletal muscle using different
techniques. We developed a multi-staining immunofluorescent method to detect vitamin D receptor
expression and co-localize it with myosin heavy chain isoform expression in skeletal muscle biopsies
in older female subjects. Serial sections were cut from frozen samples obtained by needle biopsy of
the vastus lateralis. Samples were probed with a primary vitamin D receptor monoclonal antibody
and then re-probed with a type IIa myosin heavy chain isoform-specific antibody. Independent
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unfixed sections followed a similar protocol and were probed with type IIx and type I myosin heavy
chain isoform-specific antibodies. Immunohistochemistry and fluorescent microscopy co-localized
vitamin D receptor loci and myosin heavy chain isoforms in whole skeletal muscle sections. We
quantified intranuclear vitamin D receptor staining patterns and number of individual muscle fiber
subtypes within a muscle section. Immunohistochemical staining of the vitamin D receptor was
confirmed by Western blot using the same monoclonal antibody. This multi-staining
immunofluorescent technique allows for measurement of intranuclear vitamin D receptor expression
in the context of the specific muscle fiber type profile in a single section. This method can thus be a
useful approach to study potential relationships between muscle fiber subtypes and vitamin D
receptor expression.
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Introduction
Recent data suggest that vitamin D supplementation reduces the risk of falls (Bischoff-Ferrari
et al. 2009) and improves measures of muscle performance (Pfeifer et al. 2000, 2009; Bischoff
et al. 2003) in older adults with low vitamin D status. Muscle biopsies in adults with profound
vitamin D deficiency reveal atrophy of type II (fast-twitch) muscle fibers, which are the first
fibers to be recruited when preventing a fall (McComas 1996). While the actions of vitamin D
on skeletal muscle are not well-understood, current research suggests that the effects of vitamin
D may, at least in part, be mediated through the vitamin D receptor (VDR). The VDR is a
ligand-activated transcription factor and a member of the superfamily of nuclear receptors for
steroid hormones (DeLuca 1988). The active form of vitamin D, 1α,25-dihydroxyvitamin D
[1,25(OH)2D], is believed to bind to a nuclear VDR which, in turn, modulates the expression
of genes related to the regulation of calcium transport and cell proliferation and differentiation
(Boland et al. 1985; Simpson et al. 1985). The nuclear VDR has been identified in human
skeletal muscle tissue using different techniques (Costa et al. 1986; Bischoff et al. 2001). Prior
published localization techniques, however, have not had the capability of studying potential
relationships between degree of intranuclear receptor expression and muscle fiber subtype.
The aim of this study was to co-localize VDR-positive myonuclei and specific skeletal muscle
fiber subtypes within a human skeletal muscle section. To accomplish this aim, we developed
a multiple immunofluorescent staining technique that identifies the VDR and muscle fiber
subtypes by incubating a muscle section with a monoclonal antibody to the VDR and then
myosin heavy chain (MHC) isoform-specific antibodies directly labeled with distinct
fluorophores. The intranuclear VDR signal detected using a monoclonal antibody was verified
by Western blot and compared to two alternative primary VDR antibodies.
Methods
Subjects
Eight muscle biopsy specimens used to develop the method were obtained from four healthy
postmenopausal female participants, age 65–85. The Tufts Medical Center-Tufts University
Health Sciences Campus Institutional Review Board approved the study, and written informed
consent was obtained from each participant.
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Muscle biopsy
Eight muscle biopsies were obtained from the vastus lateralis at the level of the mid-thigh under
local anesthesia (xylocaine 1%) with a 5-mm Duchenne biopsy needle and suction (Bergström
1975). The specimens were mounted in a vinyl cryomold (Tissue-Tek, USA) and secured using
a viscous mounting medium (O.C.T., Tissue-Tek, USA) and then frozen in isopentane/liquid
nitrogen slurry.
Immunohistochemistry
Eight muscle tissue specimens were cut in seven μm sections at −23°C with a cryostat
microtome (Leica CM1850, Leica Microsystems, Germany), placed onto microscope slides,
and left to air-dry at room temperature for at least 15 min. Samples were washed with phosphate
buffered saline (PBS) for 5 min, fixed in 3% neutral buffered formalin for 10 min, and then
blocked in PBS/2% goat serum for 20 min. Slides were probed overnight (4°C) with a primary
mouse/anti-human VDR/NR1I1 monoclonal antibody (clone H4537, Perseus Proteomics, Inc.;
Table 1). Subsequently, sections were probed with goat/anti-mouse IgG2A Alexa Fluor-568®
secondary antibody conjugate (Table 1). Samples that were probed with the VDR antibody,
were then re-probed with a type IIa (N2.261 IgG1) MHC isoform-specific antibody (Table 1).
Unfixed sections followed a similar protocol to identify other muscle fiber subtypes. Mouse
antibodies against human type I (A4.951 IgG1; A4.840 IgM) and IIx (212F IgG1) MHC were
used (Table 1). A rabbit anti-human antibody (IgG) raised against laminin was used to facilitate
identifying individual muscle fibers. Specific goat anti-mouse and anti-rabbit Alexa Fluor®
secondary antibodies were used for detection of MHC and laminin primary antibodies,
respectively (Table 1). Slides were mounted with 4′,6-diamidino-2-phenylindole (DAPI)-
containing mounting medium to stain myonuclei (Vectashield H-1500; Vector Laboratories,
Inc). Control sections were processed independently as described above, without primary,
secondary or both antibodies (blank control). No staining signal higher than the natural self-
fluorescence of the sections was observed (results not shown).
Digital imaging was performed through 100× and/or 400× final magnification. Adobe
Photoshop® CS3, Nikon NIS-AR (3.01) and NIH Image J software (1.37v) were employed for
data acquisition and data analysis.
Immunoblotting
To confirm VDR expression, three samples were prepared by homogenization in lysis buffer
(50 mM Tris HCl pH 7.5, 1 mM EDTA, 1 mM EGTA, 10% glycerol (v/v), 1% Triton-X (v/
v), 50 mM NaF, 5 mM Na Pyrophosphate) and then by centrifugation at 10,000 rpm/4°C.
Supernatants were stored at −80°C. Total protein concentrations of muscle extracts were
measured using the Pierce 660 nm protein assay (Thermo Fisher Scientific). To detect VDR,
30 μg of whole cell muscle lysates were loaded onto and resolved by SDS–PAGE using 10%
mini-gels (150 V/60 min with the BioRad Mini-Protean Tetra Cell System) and
electrophoretically transferred (350 mA/120 min) to 0.45 μm nitrocellulose membranes. Five
μg of 293T lysate (Santa Cruz Biotechnology, Inc.) were used as control. Membranes were
blocked in 5% non-fat dry milk (NFM)/Tris-Buffered Saline-0.05% Tween 20 (TBS-T)
solution, washed with 0.05% TBS-T, and probed with three different commercially-available
primary antibodies to the VDR (VDR/NR1I1 monoclonal antibody, clone H4537 [Perseus
Proteomics, Inc.]; VDR D-6 monoclonal antibody [sc-13133 Santa Cruz Biotechnology, Inc.]
and VDR 333C6a [sc-81423 Santa Cruz Biotechnology, Inc.] Table 1) in 5% BSA/TBS-T
(diluted 1:1,000) overnight. Membranes were then washed with 0.05% TBS-T and incubated
with different HRP-conjugated secondary antibodies (Table 1) in 1%NFM/TBS-T (diluted
1:2,000) solution for detection using SuperSignal West Pico Chemiluminescent Substrate
(Thermo Fisher Scientific).
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Results
Immunohistochemistry and fluorescent microscopy co-localized VDR and MHC isoforms in
whole skeletal muscle sections. Figure 1 illustrates incubation of muscle cryosections with
directly labeled antibodies to types I, IIa, and IIx MHC isoforms and laminin. The emission
wavelength of each different secondary antibody (Table 1) employed on the MHC isoform
staining allows simultaneous identification of the muscle fiber subtypes in two muscle sections
overlayed to create a single multi-colored image (Fig. 1). We measured the relative number of
individual muscle fiber subtypes within a cryosection, which in the Fig. 1 section revealed a
predominance of type II fibers (Table 2).
In each sample, we randomly selected ten higher magnification (400×) fields, which were
representative of the whole section. In Fig. 1, the ten fields comprised 46% of the muscle fibers
in the whole section and had a similar type I to type II muscle fiber type ratio (32% to 68%)
to that of the whole section (30% to 70%). The 400× images were captured using fluorescent
(Fig. 2a/b) and bright field microscopy (Fig. 2c). Figure 2a shows DAPI staining. Figure 2b
illustrates co-localization of VDR-positive nuclei with DAPI. Bright field images (Fig. 2c)
were used to assign the myonuclei to a particular fiber. We measured the relative number of
VDR-positive myonuclei within each muscle fiber subtype in all 10 fields. Table 3 lists the
ratio of VDR-positive myonuclei to total myonuclei by muscle fiber subtype from 10 fields
from Fig. 1. Of note, VDR immunohistochemical staining was not solely associated with
clearly identified intranuclear staining as shown in Fig. 2b (arrows).
To confirm identification of VDR by immunohistochemical staining in these cryosections, we
performed Western blot analysis using the same VDR monoclonal antibody (VDR/NR1I1).
The immunoblot was run alongside two other commercially-available primary antibodies to
the VDR (D-6 and 333C6a) to confirm the accuracy of the VDR antibody used in the
immunohistochemical stain (Fig. 3). The molecular weight band at approximately 50 kDa is
consistent across all three lanes incubated with a VDR antibody (Fig. 3).
Discussion
This study describes a multiple immunofluorescent staining technique which co-localizes the
VDR and muscle fiber subtypes in a single human skeletal muscle section. Similar to a prior
study in human skeletal muscle specimens (Bischoff et al. 2001), we identified VDR
myonuclear staining using a human monoclonal antibody to the VDR. Unlike prior studies,
however, our technique provides information on VDR expression in the context of muscle fiber
subtype and its distribution. Using type I, IIa and IIx MHC isoform-specific antibodies directly
labeled with distinct fluorophores, we were able to identify hybrid fibers which are of particular
interest when studying factors such as vitamin D supplementation that may have effects on
muscle morphology (Sorensen et al. 1979; Boland 2005; Sato et al. 2005). Our technique could
be utilized in future studies to provide information on whether the VDR has differential
expression based on muscle fiber subtype. Although we cannot generalize on a pattern of VDR
expression by fiber subtype in this study, a more extensive sampling of muscle specimens in
a larger study would allow for such an analysis. If VDR has a direct role on muscle as proposed,
this knowledge may help to explain the morphological changes noted in vitamin D deficiency
(Boland 2005) and in vitamin D repletion (Sorensen et al. 1979; Sato et al. 2005) demonstrating
a potentially selective effect on type II muscle fibers.
Notably, our technique stained peripheral areas of the muscle fiber that did not appear
connected with a myonucleus within these 7 μm sections. This preliminary finding will need
to be explored further to determine whether this signal may be representative of the putative
membrane-associated VDR believed to activate rapid, non-genomic, second messenger
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intracellular signaling cascades that influence muscle intracellular calcium regulation, muscle
contractility and myogenesis (Boland 2005). Recent animal studies indentified VDR in isolated
membrane fractions of both chick intestinal cells and chick embryonic skeletal muscle cells
(Capiati et al. 2002; Huhtakangas et al. 2004).
The strength of this method is that, by incubating a single muscle section with different specific
primary antibodies to different MHC isoforms, it successfully reduces the amount of muscle
tissue, reagents, and time needed to perform these analyses. A limitation in this study was that
we did not verify the VDR signal in muscle using an inhibitor or knockout model; however,
we confirmed VDR expression in muscle sections by Western blot analysis using the same
antibody and compared it to other antibodies to further corroborate our findings.
In summary, this technique co-localizes VDR using a human monoclonal antibody and type I,
IIa, and IIx muscle fibers using specific antibodies to MHC isoforms in a sample obtained from
a human skeletal muscle biopsy. The method identifies and quantifies VDR-positive myonuclei
in skeletal muscle, identifies specific MHC isoforms and VDR positive myonuclei within
individual muscle fiber subtypes, and identifies peripheral VDR staining patterns that need
further investigation. Use of this technique in a large sample of muscle specimens would
provide patterns of VDR expression and its associations with MHC iso-forms in human muscle.
Acknowledgments
This material is based upon work supported by the U.S. Department of Agriculture, Agricultural Research Service,
under agreement No. 58-1950-7-707. Any opinions, findings, conclusion, or recommendations expressed in this
publication are those of the author(s) and do not necessarily reflect the view of the U.S. Dept of Agriculture.
The A4.951, A4.840, and N2.261 monoclonal antibodies developed by H. M. Blau were obtained from the
Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The
University of Iowa, Department of Biology, Iowa City, IA 52242. The 212F mAb was produced in-house from
hybridomas generously donated by Dr. Peter Merrifield, University of Ontario, Canada. We are grateful to the staff
of the Metabolic Research Unit at the Jean Mayer USDA HNRCA at Tufts University for assistance in carrying out
on this study. LC is supported by NIH KL2 RR025751. The study was funded by the Jean Mayer USDA HNRCA at
Tufts University and P30 AG031679.
References
Bergström J. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand
J Clin Lab Invest 1975;35(7):609–616. [PubMed: 1108172]
Bischoff HA, Borchers M, et al. In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal
muscle tissue. Histochem J 2001;33(1):19–24. [PubMed: 11352397]
Bischoff HA, Stahelin HB, et al. Effects of vitamin D and calcium supplementation on falls: a randomized
controlled trial. J Bone Miner Res 2003;18(2):343–351. [PubMed: 12568412]
Bischoff-Ferrari HA, Dawson-Hughes B, et al. Fall prevention with supplemental and active forms of
vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009;339:b3692. [PubMed:
19797342]
Boland, R. Vitamin D and muscle. In: Feldman, D.; Pike, JW.; Glorieux, GH., editors. Vitamin D.
Elsevier; Amsterdam: 2005. p. 883-897.
Boland R, Norman A, et al. Presence of a 1,25-dihydroxy-vitamin D3 receptor in chick skeletal muscle
myoblasts. Biochem Biophys Res Commun 1985;128(1):305–311. [PubMed: 2985076]
Capiati D, Benassati S, et al. 1, 25(OH)2-vitamin D3 induces translocation of the vitamin D receptor
(VDR) to the plasma membrane in skeletal muscle cells. J Cell Biochem 2002;86(1):128–135.
[PubMed: 12112023]
Costa EM, Blau HM, et al. 1,25-dihydroxyvitamin D3 receptors and hormonal responses in cloned human
skeletal muscle cells. Endocrinology 1986;119(5):2214–2220. [PubMed: 3021437]
DeLuca HF. The vitamin D story: a collaborative effort of basic science and clinical medicine. Faseb J
1988;2(3):224–236. [PubMed: 3280376]
Ceglia et al. Page 5
J Mol Histol. Author manuscript; available in PMC 2010 October 20.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Huhtakangas JA, Olivera CJ, et al. The vitamin D receptor is present in caveolae-enriched plasma
membranes and binds 1alpha,25(OH)2-vitamin D3 in vivo and in vitro. Mol Endocrinol 2004;18(11):
2660–2671. [PubMed: 15272054]
McComas, A. Skeletal muscle: form and function. Human Kinetics Publishers, Inc; Champaign, IL: 1996.
Pfeifer M, Begerow B, et al. Effects of a short-term vitamin D and calcium supplementation on body
sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 2000;15(6):1113–
1118. [PubMed: 10841179]
Pfeifer M, Begerow B, et al. Effects of a long-term vitamin D and calcium supplementation on falls and
parameters of muscle function in community-dwelling older individuals. Osteoporos Int 2009;20(2):
315–322. [PubMed: 18629569]
Sato Y, Iwamoto J, et al. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip
fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis 2005;20(3):187–192.
[PubMed: 16088114]
Simpson RU, Thomas GA, et al. Identification of 1,25-dihydroxyvitamin D3 receptors and activities in
muscle. J Biol Chem 1985;260(15):8882–8891. [PubMed: 2991224]
Sorensen OH, Lund B, et al. Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-
hydroxycholecalciferol and calcium. Clin Sci (Lond) 1979;56(2):157–161. [PubMed: 477197]
Ceglia et al. Page 6
J Mol Histol. Author manuscript; available in PMC 2010 October 20.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 1.
Composite image (100×) of multi-immunofluorescent staining of MHC isoforms in a human
skeletal muscle tissue section. Colorization patterns are: dark green = type I, green/blue =
hybrid I/IIa, blue = type IIa, red = type IIx, purple = hybrid IIax, and light green = laminin
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Fig. 2.
VDR-positive myonuclei in skeletal muscle section at 400× magnification showing: a DAPI
staining myonuclei; b co-localization of VDR-positive myonuclei with DAPI; c bright field
microscopy
Ceglia et al. Page 8
J Mol Histol. Author manuscript; available in PMC 2010 October 20.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 3.
VDR expression in whole cell lysate of human skeletal muscle is shown using three
commercially available primary antibodies. From left to right are VDR (D-6), VDR (333C6a)
and VDR (NR1I1). VDR expression was verified by use of human VDR transfected 293T cell
lysate from Santa Cruz Biotechnology, Inc
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Table 2
Muscle fiber type profile of Fig. 1
Muscle fiber type Number of fibers Percent (%)
Type I 200 28.6
Hybrid I–IIa 9 1.3
Type IIa 196 28.0
Type IIx 198 28.3
Hybrid IIa–IIx 96 13.7
All type Ia 209 29.9
All type IIb 490 70.1
Total 699 100
a
Type I fibers consist of type I and hybrid I–IIa
b
Type II fibers consist of type IIa, type IIx and hybrid IIa–IIx
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Table 3
Relative number of VDR-positive myonuclei in 10 randomly selected 400 × fields
Muscle fiber type Number of VDR- positive nuclei Total number of nuclei Ratio (VDR/Total)
Type I 165 178 0.93
Hybrid I–IIa 14 14 1.00
Type IIa 155 180 0.86
Type IIx 145 170 0.85
Hybrid IIa–IIx 70 83 0.84
All type Ia 179 192 0.93
All type IIb 370 433 0.86
Total 549 625 0.88
a
Type I fibers consist of type I and hybrid I–IIa
b
Type II fibers consist of type IIa, type IIx and hybrid IIa–IIx
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